- 主题
- 8
- 您的身份
- 游客
- 就诊医院
- 无
- 病理报告
- 未确诊
- 目前状态
- 游客
参加活动:0 次 组织活动:0 次

您的身份游客
病理报告未确诊
就诊医院无
目前状态游客
最后登录2019-4-10

|
发表于 2017-3-7 21:00:20
|
显示全部楼层
来自: 中国辽宁大连
可以考虑PD-1
http://www.dana-farber.org/Newsr ... gkin-lymphomas.aspx
The research involved five patients with recurrent or refractory primary central nervous system lymphoma (PCNSL) or primary testicular lymphoma (PTL) who were treated with nivolumab, a drug that blocks a key protein, PD-1, on immune system T cells. The blocking allows the T cells to ignore signals that would dampen their attack on the lymphoma cells. Four of the patients had a complete response to the drug – showing no evidence of tumor on brain imaging – and one had a partial response. |
|